Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method.

IF 2.8 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Hongqi Xue, Georg Ferber, Ellen Freebern, Borje Darpo
{"title":"Sample size determination for cardiodynamic ECG assessment using the Concentration-QTc analysis method.","authors":"Hongqi Xue, Georg Ferber, Ellen Freebern, Borje Darpo","doi":"10.1007/s10928-025-09998-z","DOIUrl":null,"url":null,"abstract":"<p><p>Concentration-QTc (C-QTc) analysis was accepted to serve as an alternative to the by-time point analysis with intersection-union test (IUT) as the primary basis for decisions to classify the arrhythmogenic risk of a drug by ICH E14 Q&As (R3) in December 2015. Since then, this analysis method has been widely applied by industry as it significantly reduces the sample size to achieve the same power as with IUT. There are many model-based power calculation approaches available for C-QTc through simulation in the literature, however, there is still no standard method with a clear formula to determine the sample size for C-QTc analysis to exclude a small effect on the QTc interval. The current model-based simulation approaches are too complicated to prevent them from being widely used, which is not commensurate with the popular status. We have developed a systematic method based on t-tests to determine the sample size for different study designs using the C-QTc analysis method and applied it to many studies. The results of the sample sizes utilizing this method are consistent with simulation studies and validated by real analyses.</p>","PeriodicalId":16851,"journal":{"name":"Journal of Pharmacokinetics and Pharmacodynamics","volume":"52 5","pages":"48"},"PeriodicalIF":2.8000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacokinetics and Pharmacodynamics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10928-025-09998-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Concentration-QTc (C-QTc) analysis was accepted to serve as an alternative to the by-time point analysis with intersection-union test (IUT) as the primary basis for decisions to classify the arrhythmogenic risk of a drug by ICH E14 Q&As (R3) in December 2015. Since then, this analysis method has been widely applied by industry as it significantly reduces the sample size to achieve the same power as with IUT. There are many model-based power calculation approaches available for C-QTc through simulation in the literature, however, there is still no standard method with a clear formula to determine the sample size for C-QTc analysis to exclude a small effect on the QTc interval. The current model-based simulation approaches are too complicated to prevent them from being widely used, which is not commensurate with the popular status. We have developed a systematic method based on t-tests to determine the sample size for different study designs using the C-QTc analysis method and applied it to many studies. The results of the sample sizes utilizing this method are consistent with simulation studies and validated by real analyses.

使用浓度- qtc分析方法确定心电动力学心电图评估的样本量。
2015年12月,ICH E14 Q&As (R3)认可浓度- qtc (C-QTc)分析可替代按时间点分析、交叉结合试验(IUT)作为判定药物致心律失常风险的主要依据。从那时起,这种分析方法被广泛应用于工业,因为它大大减少了样本量,达到了与IUT相同的功率。文献中对C-QTc进行仿真的基于模型的功率计算方法有很多,但尚没有明确公式确定C-QTc分析的样本量以排除对QTc区间的小影响的标准方法。目前基于模型的仿真方法由于过于复杂而无法得到广泛应用,这与当前的流行状况不相称。我们开发了一种基于t检验的系统方法,使用C-QTc分析方法来确定不同研究设计的样本量,并将其应用于许多研究。该方法的样本量计算结果与模拟结果一致,并得到了实际分析结果的验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.90
自引率
4.00%
发文量
39
审稿时长
6-12 weeks
期刊介绍: Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers the area of pharmacometrics. The journal is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in drug development, clinical care, and the understanding of drug action. The journal publishes on a variety of topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action in humans, animals, in vitro, or in silico; modeling and simulation methodology, including optimal design; precision medicine; systems pharmacology; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, orpharmacodynamics). Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome. The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence, quality of life analyses, and artificial intelligence. The Journal of Pharmacokinetics and Pharmacodynamics is an official journal of the International Society of Pharmacometrics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信